T-cell frequencies of CD8+ γδ and CD27+ γδ cells in the stem cell graft predict the outcome after allogeneic hematopoietic cell transplantation

[1]  K. Schilbach,et al.  The potential role of γδ T cells after allogeneic HCT for leukemia. , 2018, Blood.

[2]  A. Gaballa,et al.  Expansion of Gammadelta T Cells from Cord Blood: A Therapeutical Possibility , 2018, Stem cells international.

[3]  M. Nolte,et al.  Memory CD8+ T cells support the maintenance of hematopoietic stem cells in the bone marrow , 2018, Haematologica.

[4]  S. Jang,et al.  Reconstitution of T and NK cells after haploidentical hematopoietic cell transplantation using αβ T cell–depleted grafts and the clinical implication of γδ T cells , 2018, Clinical transplantation.

[5]  I. Nederlof,et al.  Risk Factors for Severe Acute Graft-versus-Host Disease in Donor Graft Composition. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[6]  Zheng Xiang,et al.  Dual Face of Vγ9Vδ2-T Cells in Tumor Immunology: Anti- versus Pro-Tumoral Activities , 2017, Front. Immunol..

[7]  M. Dieu-Nosjean,et al.  Key Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications , 2017, Front. Immunol..

[8]  Adnane Achour,et al.  Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease , 2017, Front. Immunol..

[9]  R. Geffers,et al.  Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection , 2017, Nature Immunology.

[10]  S. Fisher,et al.  Increased regulatory T cell graft content is associated with improved outcome in haematopoietic stem cell transplantation: a systematic review , 2017, British journal of haematology.

[11]  J. Marsal,et al.  CD8αβ+ γδ T Cells: A Novel T Cell Subset with a Potential Role in Inflammatory Bowel Disease , 2016, The Journal of Immunology.

[12]  J. Mattsson,et al.  Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation , 2016, Journal of immunology research.

[13]  M. Itälä-Remes,et al.  A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation , 2016, Haematologica.

[14]  R. Dikshit,et al.  IL17 producing γδT cells induce angiogenesis and are associated with poor survival in gallbladder cancer patients , 2016, International journal of cancer.

[15]  He Huang,et al.  A promising sword of tomorrow: Human γδ T cell strategies reconcile allo-HSCT complications. , 2016, Blood reviews.

[16]  D. Roberts,et al.  High proportions of regulatory T cells in PBSC grafts predict improved survival after allogeneic haematopoietic SCT , 2015, Bone Marrow Transplantation.

[17]  M. Remberger,et al.  Effect of Total Nucleated and CD34(+) Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[18]  A. Moretta,et al.  γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytes. , 2015, Blood.

[19]  J. Jonkers,et al.  IL17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis , 2015, Nature.

[20]  A. Gennery,et al.  Hematopoietic stem cell transplantation for primary immunodeficiencies. , 2014, Hematology/oncology clinics of North America.

[21]  S. Thunberg,et al.  Alpha/Beta T-Cell Depleted Grafts as an Immunological Booster to Treat Graft Failure after Hematopoietic Stem Cell Transplantation with HLA-Matched Related and Unrelated Donors , 2014, Journal of immunology research.

[22]  J. Ritz,et al.  Current issues in chronic graft-versus-host disease. , 2014, Blood.

[23]  J. Mattsson,et al.  Cord blood graft composition impacts the clinical outcome of allogeneic stem cell transplantation , 2014, Transplant infectious disease : an official journal of the Transplantation Society.

[24]  F. Locatelli,et al.  Negative depletion of α/β+ T cells and of CD19+ B lymphocytes: a novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation. , 2013, Immunology letters.

[25]  H. Oberg,et al.  Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity , 2013, Oncoimmunology.

[26]  P. Vantourout,et al.  Six-of-the-best: unique contributions of γδ T cells to immunology , 2013, Nature Reviews Immunology.

[27]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[28]  S. Grace,et al.  The role of Vδ2-negative γδ T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation. , 2010, Blood.

[29]  M. Ciofani,et al.  Determining γδ versus αβ T cell development , 2010, Nature Reviews Immunology.

[30]  W. Born,et al.  gammadelta T cell subsets: a link between TCR and function? , 2010, Seminars in immunology.

[31]  A. Hayday,et al.  CD27 is a thymic determinant of the balance between interferon-γ- and interleukin 17–producing γδ T cell subsets , 2009, Nature Immunology.

[32]  G. Ehninger,et al.  The Graft Content of Donor T Cells Expressing γδTCR+ and CD4+foxp3+ Predicts the Risk of Acute Graft versus Host Disease after Transplantation of Allogeneic Peripheral Blood Stem Cells from Unrelated Donors , 2007, Clinical Cancer Research.

[33]  J. Ferrara,et al.  Critical role of host γδ T cells in experimental acute graft-versus-host disease , 2005 .

[34]  L. Lamb,et al.  γδ T cells: A new frontier for immunotherapy? , 2005 .

[35]  M Hummel,et al.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.

[36]  Julia M. Lewis,et al.  Resident Skin-specific γδ T Cells Provide Local, Nonredundant Regulation of Cutaneous Inflammation , 2002, The Journal of experimental medicine.

[37]  Shoji Uehara,et al.  A Role for CCR9 in T Lymphocyte Development and Migration1 , 2002, The Journal of Immunology.

[38]  P. Chilton,et al.  The role of alphabeta- and gammadelta-T cells in allogenic donor marrow on engraftment, chimerism, and graft-versus-host disease. , 2001, Transplantation.

[39]  P. Henslee-Downey,et al.  Human γδ+ T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response , 2001, Bone Marrow Transplantation.

[40]  W. Drobyski,et al.  Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease. , 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[41]  J Hermans,et al.  Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation , 1998, The Lancet.

[42]  M. Horowitz,et al.  Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation , 1997, Bone Marrow Transplantation.

[43]  A. Hayday,et al.  Propagation and regulation of systemic autoimmunity by gammadelta T cells. , 1996, Journal of immunology.

[44]  A. Gee,et al.  Rapid Communication: Increased Frequency of TCRγδ+ T Cells in Disease-Free Survivors Following T Cell-Depleted, Partially Mismatched, Related Donor Bone Marrow Transplantation for Leukemia , 1996 .

[45]  J. Bluestone,et al.  Lethal murine graft-versus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens. , 1996, Blood.

[46]  G. Macdonald,et al.  Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality. , 1995, Journal of immunology.

[47]  K. Pfeffer,et al.  A major fraction of human intraepithelial lymphocytes simultaneously expresses the γ/δ T cell receptor, the CD8 accessory molecule and preferentially uses the Vδ1 gene segment , 1991 .

[48]  P. Thomas,et al.  Gamma delta T cell reconstitution is associated with fewer infections and improved event-free survival after hematopoietic stem cell transplantation for pediatric leukemia. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[49]  D. Baarle,et al.  γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia , 2013, Leukemia.